CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates
Nancy J. Sullivan(National Institute of Allergy and Infectious Diseases), Gary J. Nabel(National Institutes of Health), Clement Asiedu(National Institutes of Health), Richard A. Koup(Aaron Diamond AIDS Research Center), Peter B. Jahrling(National Institutes of Health), Saran Bao(National Institutes of Health), Keith A. Reimann(University of Massachusetts Chan Medical School), Joshua C. Johnson(National Institutes of Health), Srinivas Rao(National Institutes of Health), Thomas W. Geisbert(The University of Texas Medical Branch at Galveston), Lisa E. Hensley(National Center for Emerging and Zoonotic Infectious Diseases), Gene G. Olinger(Health Affairs), Mario Roederer(National Institutes of Health), Daphne A. Stanley(National Institutes of Health), Michael Bailey(General Department of Preventive Medicine), Joan B. Geisbert(The University of Texas Medical Branch at Galveston), Anna N. Honko
Cited by 227
Related Papers
A human memory T cell subset with stem cell–like properties
|Nature Medicine|2011|2k
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
|Science|2010|1.8k
Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation
|Journal of Immunological Methods|2003|1.6k
T-cell quality in memory and protection: implications for vaccine design
|Nature reviews. Immunology|2008|1.6k
Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major
|Nature Medicine|2007|1.4k